UnitedHealth Group is far from the perfect stock, but it is an appealing buy because it can learn from its errors and ...

UnitedHealth Group stock is a top dividend growth stock with solid returns, reliable yield, and long-term growth prospects.

A political battle continues within the U.S. government over renewing expired Affordable Care Act (ACA) subsidies. The ...

Shares of the healthcare giant are still down more than 30% year to date, after plunging as much as 53% at one point. Should ...

In recent months, UnitedHealth Group has raised premiums by around 20–30%, updated its 2025 earnings guidance, and faced ...

Mairs & Power, an investment advisor, released the third-quarter 2025 investor letter for the “Mairs & Power Balanced Fund.” A copy of the letter can be downloaded here. As we move into 2025, the ...

UnitedHealth Group Inc. defeated an insurance reimbursement suit Tuesday after a federal appeals court affirmed the Employee ...

UnitedHealth Group has agreed to sell its last South American business Banmedica to Brazilian private equity group Patria ...

Discover why UnitedHealth Group (UNH) is rated Buy, with margin recovery, earnings growth, and 154% upside potential.

UnitedHealth Group, the company that owns healthcare conglomerate UnitedHealth, said on Thursday that it is cooperating with the federal government as it fields criminal and civil requests from ...

UnitedHealth Group has reached a deal to sell its Latin American business Banmedica for $1 billion, according to media ...

Former UnitedHealth Group CEO William McGuire joins mediation team for Fairview and University of Minnesota merger negotiations.